Plans for the acquisition were announced in December. The move pushes Henry Schein, a dental medtech company, into the orthopedic space.
TriMed had 2023 net sales of about $52 million, and the company develops products for the lower and upper extremities. David Medoff, TriMed’s chief commercial officer, and Robert Medoff, MD, medical advisor, will remain part of the company’s management team.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
